Oncternal Therapeutics, Inc.
ONCTDelisted Mar 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001260990
Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Oncternal Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +2 vs. Q1 2024
- Shares held
- 483.1K
- +33.1K (+7.4%) vs. Q1 2024
- Total value
- $3.67M
- −$378.7K (−9.4%) vs. Q1 2024
- New holders
- 4
- 5 more added
- Sold out
- 2
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75 |
| Q1 2026 | 1 | $74 |
| Q4 2025 | 2 | $169 |
| Q3 2025 | 1 | $73 |
| Q2 2025 | 1 | $74 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 4 | $10 |
| Q3 2024 | 23 | $471.0K |
| Q2 2024 | 26 | $3.67M |
| Q1 2024 | 24 | $4.05M |
| Q4 2023 | 41 | $4.53M |
| Q3 2023 | 52 | $2.81M |
| Q2 2023 | 53 | $3.26M |
| Q1 2023 | 55 | $7.86M |
| Q4 2022 | 59 | $9.31M |
| Q3 2022 | 61 | $8.79M |
| Q2 2022 | 75 | $12.6M |
| Q1 2022 | 79 | $18.6M |
| Q4 2021 | 84 | $30.5M |
| Q3 2021 | 77 | $56.8M |
| Q2 2021 | 85 | $65.2M |
| Q1 2021 | 67 | $82.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Oncternal Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 143,043 | $1.09M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 102,936 | $782.3K | 0.00% | −159−0.2% | Reduced |
| BlackRock Inc. | 39,278 | $298.5K | 0.00% | 00.0% | Unchanged |
| Quantum Private Wealth, LLC | 26,902 | $204.5K | 0.07% | −904−3.3% | Reduced |
| Dimensional Fund Advisors LP | 26,298 | $199.9K | 0.00% | +406+1.6% | Added |
| Geode Capital Management, LLC | 25,879 | $196.7K | 0.00% | +1,800+7.5% | Added |
| Pasadena Private Wealth, LLC | 25,000 | $190.0K | 0.04% | +25,000 | New |
| Richmond Brothers, Inc. | 24,696 | $187.7K | 0.37% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 17,205 | $130.8K | 0.00% | +300+1.8% | Added |
| Brighton Jones LLC | 16,923 | $128.6K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 15,206 | $115.6K | 0.00% | +5,012+49.2% | Added |
| Morgan Stanley | 15,067 | $114.5K | 0.00% | +4,267+39.5% | Added |
| Acadian Asset Management LLC | 1,829 | $13.0K | 0.00% | −120−6.2% | Reduced |
| JPMorgan Chase & Co | 1,004 | $7.63K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 621 | $4.72K | 0.00% | −43−6.5% | Reduced |
| Wells Fargo & Company | 300 | $2.28K | 0.00% | −22−6.8% | Reduced |
| North Star Investment Management Corp. | 250 | $1.90K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 182 | $1.38K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 150 | $1.14K | 0.00% | −137−47.7% | Reduced |
| UBS Group AG | 100 | $760 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 100 | $760 | 0.00% | +100 | New |
| FMR LLC | 72 | $547 | 0.00% | +72 | New |
| Bank of America Corp | 22 | $167 | 0.00% | +22 | New |
| Steward Partners Investment Advisory, LLC | 15 | $114 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 15 | $114 | 0.00% | 00.0% | Unchanged |
| Nemes Rush Group LLC | 3 | $23 | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −2,472−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |